パイロジェン検査市場：製品タイプ、検査タイプ、エンドユーザー別-2024-2030年の世界予測

パイロジェン検査市場規模は、2023年に12億4,000万米ドルと推定され、2024年には13億8,000万米ドルに達し、CAGR 11.64%で2030年には26億8,000万米ドルに達すると予測されています。

パイロジェン検査は、バイオテクノロジー、医療機器、製薬産業において、注射用医薬品、医療機器、その他人体に直接接触する製品の安全性と品質を確保するために採用されている重要な手順です。パイロジェンとは、少量であっても人体に取り込まれると発熱を引き起こす物質のことです。これらの物質には、主にグラム陰性菌の細胞壁の構成成分である細菌性内毒素や、発熱反応を誘発するその他の微生物および非微生物汚染物質が含まれます。医薬品の安全性と有効性に関する認識と警戒の高まりにより、発熱性物質を含む汚染物質検査への注目が高まっています。さらに、世界中の保健当局が定める厳しい規制や基準により、包括的なパイロジェン検査が必要とされ、検査サービスや製品に対する需要が高まっています。しかし、先進的なパイロジェン検査法のコストは高く、特に中小企業（SME）にとっては法外なものとなる可能性があります。さらに、動物を使用しない検査法へのシフトが進んでいるため、合成法や組み換え法によるパイロジェン検査の技術革新に大きな機会がもたらされています。

製品タイプ：検査プロセスを自動化、促進、強化するためのアッセイ、キット、試薬の需要の増加

アッセイ、キット、試薬は、Limulus Amebocyte Lysate（LAL）検査、Monocyte Activation Test（MAT）検査、Rabbit Pyrogen Test（RPT）検査など、特定の検査手法向けに設計されています。これらの製品は、パイロジェンの存在と濃度を検出するために必要な生化学的および生物学的成分を提供します。パイロジェン検査に含まれる機器には、検査プロセスを自動化、促進、強化するために使用される装置や機器が含まれます。このセグメントには、エンドトキシン検出システム、インキュベーター、分光光度計などの特殊な装置が含まれます。機器は、基本的な検査機器から、ハイスループット検査に対応し、感度を高め、精度を確保する高度な自動化システムまで多岐にわたる。パイロジェン検査サービスは、専門的な研究所や企業が提供するサービスをカバーします。これらのサービスは、エンド・ツー・エンドのパイロジェン検査から、試験デザインや規制遵守に関するコンサルテーションまで多岐にわたります。試験の複雑さ、専門知識の必要性、ラボのキャパシティーの制約などから、パイロジェン検査を外注する組織向けのサービスです。

エンドユーザー：バイオテクノロジー企業におけるパイロジェン検査需要の増加

バイオテクノロジー企業は、治療および診断ソリューションの開発の最前線にあり、多くの場合、新規の生物学的薬剤を採用しています。このような状況において、パイロジェン検査はこれらの生物学的製剤に発熱を誘発するような汚染物質が含まれていないことを保証します。これらの企業にとっての最大の懸念は、患者に発熱反応を引き起こす可能性のある組換えタンパク質、ワクチン、細胞治療薬の汚染の可能性です。このような企業は、従来の細菌性エンドトキシンにとどまらず、より広範なパイロジェンを検出する単球活性化試験（MAT）のような革新的で高感度な検査法を好む傾向があります。医療機器企業は、製品の安全性評価の極めて重要な部分としてパイロジェン検査を組み込んでいます。人体に直接接触する機器、特に血管内または髄腔内使用を意図した機器は、汚染された場合に発熱反応を引き起こすリスクがあります。これらの企業にとっての第一の課題は、単純な手術器具から複雑なインプラントに至るまで、膨大な種類の器具の無菌性と非パイロジェン性を確保することです。非経口輸液を含む幅広い医薬品を製造する製薬会社は、患者の副作用を防ぐため、製品がパイロジェンフリーであることを保証しなければならないです。この分野は、生産される医薬品の量と種類が膨大であることから、パイロジェン検査サービスの最も広範なユーザーです。

地域別インサイト

南北アメリカ、特に米国とカナダはパイロジェン検査の重要な市場です。南北アメリカ市場は、高度なヘルスケアインフラ、厳格な規制政策、主要な製薬・バイオテクノロジー企業の存在に起因しています。米国は、革新的な検査ソリューションにつながる強固な研究エコシステムで際立っています。同市場は、すべての注射・埋め込み型医療機器に厳格なパイロジェン検査を義務付けるFDA規制によって支えられています。EU諸国は、厳格なパイロジェン検査を通じて製品の安全性を確保する姿勢を強調する欧州薬局方規格の採用により、規制基準と市場規模をリードしています。パイロジェン検査の需要は、大規模な製薬産業基盤と製品の安全性に関する意識の高まりによって牽引されています。中東とアフリカは、成長する可能性を秘めた新興市場です。ヘルスケアインフラと医薬品製造能力の拡大に伴い、パイロジェン検査への関心が高まっています。アジア太平洋地域は、中国、日本、インドを含む国々の製薬産業の拡大により、パイロジェン検査市場が急成長しています。同地域では、ヘルスケアや研究への投資が増加し、品質管理や安全基準が重視されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはパイロジェン検査市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、パイロジェン検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.パイロジェン検査市場の市場規模および予測は？

2.パイロジェン検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.パイロジェン検査市場の技術動向と規制枠組みは？

4.パイロジェン検査市場における主要ベンダーの市場シェアは？

5.パイロジェン検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症と慢性疾患の発生率の上昇
    • 医薬品、生物製剤、医療機器製品の生産増加
    • 世界中の保健当局が定める厳格な規制と基準
  • 抑制要因
    • 高度なパイロジェン検査メソッドに関連する高コスト
  • 機会
    • 製薬企業やバイオテクノロジー企業による研究開発活動への投資の増加
    • バイオテクノロジーとパイロジェン検査技術の技術的進歩
  • 課題
    • パイロジェン検査に関連する運用上および倫理上の懸念
• 市場セグメンテーション分析
  • 製品タイプ：検査プロセスを自動化、促進、強化するためのアッセイ、キット、試薬の需要の増加
  • エンドユーザー：バイオテクノロジー企業全体でパイロジェン検査の需要が増加
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 パイロジェン検査市場：製品タイプ別

• アッセイ、キット、試薬
• 機器
• サービス

第7章 パイロジェン検査市場テストタイプ別

• リムルスアメーボサイトライセート
• 単球活性化試験
• ウサギのテスト
• 組み換えカスケード試薬
• 組み換え因子C

第8章 パイロジェン検査市場：エンドユーザー別

• バイオテクノロジー企業
• 医療機器企業
• 製薬会社

第9章 南北アメリカのパイロジェン検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のパイロジェン検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのパイロジェン検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • チャールズリバーラボラトリーズ、効率的で動物を使わない試験を実現するエンドセーフトリリウムrCRカートリッジを発売
  • ロンザ、先進の迅速MATシステムを発表
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
• FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. PYROGEN TESTING MARKET DYNAMICS
• FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 44. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 45. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 46. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 53. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 54. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 55. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 56. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 57. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 58. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 62. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 63. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 64. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 65. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 66. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 69. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 70. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 71. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 72. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 73. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 74. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 75. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 78. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 79. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 80. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 81. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 82. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 83. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 86. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 87. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 88. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 89. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 90. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 96. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 98. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 100. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 102. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 105. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 106. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 107. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 108. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 109. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 110. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 111. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 114. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 115. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 116. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 117. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 118. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 119. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 120. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 121. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 122. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 123. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 124. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 125. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 126. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 127. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 130. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 131. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 132. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 133. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 134. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 135. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 138. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 139. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 140. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 141. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 142. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 143. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 144. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 145. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 146. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 147. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 148. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 149. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 150. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 151. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 152. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 153. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 154. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 155. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 156. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 157. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 158. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 159. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 162. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 163. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 164. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 165. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 166. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 167. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 168. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 170. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 172. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 174. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 176. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 177. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 178. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 179. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 180. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 181. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 182. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 183. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 184. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 185. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 186. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 187. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 188. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 189. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 190. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 191. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 192. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 193. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 194. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 195. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 196. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 197. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 198. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 199. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 211. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 212. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 213. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 214. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 215. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 216. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 217. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 218. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 219. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 220. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 221. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 222. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 223. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 224. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 225. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 228. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 229. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 230. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 231. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 232. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 233. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 234. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 235. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 236. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 237. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 238. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 239. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 240. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 241. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 244. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 245. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 246. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 247. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 248. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 249. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 252. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 253. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 254. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 255. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 256. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 257. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 258. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 259. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 260. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 261. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 262. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 263. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 264. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 265. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 268. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 269. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 270. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 271. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 272. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 273. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 274. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 275. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 276. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 277. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 278. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 279. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 280. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 281. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 284. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 285. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 286. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 287. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 288. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 289. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 290. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 291. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 292. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 293. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 294. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 295. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 296. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 297. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 298. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 299. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 300. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 301. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 302. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 303. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 304. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 305. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 306. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 307. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 308. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 309. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 310. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 311. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 312. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 313. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 314. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 316. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 318. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 320. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 322. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 324. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 326. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 327. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 328. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 330. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 331. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 332. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 333. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 334. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 335. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 336. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 337. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 338. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 339. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 340. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 341. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 342. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 343. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 344. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 345. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 346. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 347. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 348. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 349. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
• TABLE 350. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
• TABLE 351. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
• TABLE 352. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
• TABLE 353. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 354. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 355. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 356. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE

[197 Pages Report] The Pyrogen Testing Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.38 billion in 2024, at a CAGR 11.64% to reach USD 2.68 billion by 2030.

Pyrogen testing is a critical procedure employed in the biotechnology, medical device, and pharmaceutical industries to ensure the safety and quality of injectable pharmaceuticals, medical devices, and other products that come in direct contact with the human body. Pyrogens are substances that, even in small amounts, can induce fever when introduced into the human body. These substances primarily include bacterial endotoxins, which are constituents of Gram-negative bacteria cell walls, and other microbial and non-microbial contaminants that elicit a pyrogenic response. Increased awareness and vigilance regarding drug safety and efficacy have heightened the focus on contaminant testing, including pyrogens. Moreover, stringent regulations and standards set by health authorities worldwide necessitate comprehensive pyrogen testing, fuelling demand for testing services and products. However, the high cost of advanced pyrogen testing methods can be prohibitive, especially for small and medium-sized enterprises (SMEs). Furthermore, the growing shift towards animal-free testing methods presents significant opportunities for innovation in synthetic and recombinant pyrogen testing methods.

Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes

Assays, kits, and reagents are designed for specific testing methodologies, such as the Limulus Amebocyte Lysate (LAL) test, Monocyte Activation Test (MAT), and Rabbit Pyrogen Test (RPT), among others. These products provide the biochemical and biological components necessary for detecting the presence and concentration of pyrogens. Instrumentation in pyrogen testing encompasses the devices and equipment used to automate, facilitate, or enhance the testing processes. This segment includes endotoxin detection systems, incubators, and spectrophotometers, among other specialized apparatuses. Instruments range from basic laboratory equipment to sophisticated automated systems that handle high-throughput testing, enhance sensitivity, and ensure precision. The pyrogen testing services cover the offerings provided by specialized laboratories and companies. These services range from end-to-end pyrogen testing to consultation on test design and regulatory compliance. Services cater to organizations that outsource pyrogen testing due to the high complexity of tests, the need for specialized expertise, or constraints in laboratory capacity.

End-User: Increasing demand of pyrogen testing across biotechnology companies

Biotechnology companies are at the forefront of developing therapeutic and diagnostic solutions, often employing novel biological agents. In this context, pyrogen testing ensures these biological products are free from fever-inducing contaminants. The primary concern for these companies is the potential contamination of recombinant proteins, vaccines, and cell therapies, which can provoke pyrogenic responses in patients. These entities tend to prefer innovative, sensitive testing methods such as the Monocyte Activation Test (MAT), which detect a broader range of pyrogens beyond the traditional bacterial endotoxins. Medical device companies incorporate pyrogen testing as a pivotal part of product safety assessments. Devices that come into direct contact with the human body, especially those intended for intravascular or intrathecal use, risk causing pyrogenic reactions if contaminated. The primary challenge for these companies is ensuring the sterility and non-pyrogenicity of a vast array of devices, from simple surgical instruments to complex implants. Pharmaceutical companies producing a wide range of medicinal products, including parenteral solutions, must ensure their products are pyrogen-free to prevent adverse patient reactions. This sector is the most extensive user of pyrogen testing services, given the vast quantities and varieties of drugs produced.

Regional Insights

The Americas, particularly the United States and Canada, represent a substantial market for pyrogen testing. The Americas market is attributed to the advanced healthcare infrastructure, strict regulatory policies, and the presence of key pharmaceutical and biotechnology companies. The United States stands out with its robust research ecosystem, leading to innovative testing solutions. The market is buoyed by FDA regulations that mandate rigorous pyrogen testing for all injectable and implantable medical devices. The EU countries are leading in regulatory standards and market size with the adoption of the European Pharmacopoeia standards, which underscores the commitment to ensuring product safety through rigorous pyrogen testing. The demand for pyrogen testing is driven by a large pharmaceutical industry base and heightened awareness regarding product safety. The Middle East and Africa present a nascent market with growing potential. The interest in pyrogen testing is increasing with the expansion of healthcare infrastructure and pharmaceutical manufacturing capabilities. The Asia Pacific region is witnessing rapid growth in the pyrogen testing market driven by expanding pharmaceutical industries in countries including China, Japan, and India. The region benefits from increasing investments in healthcare and research, coupled with a heightened focus on quality control and safety standards.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pyrogen Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pyrogen Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Associates of Cape Cod, Inc., bioMerieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Ellab A/S by Novo Nordisk A/S, Eurofins Scientific SE, FUJIFILM Corporation, GenScript Biotech Corporation, Indoor Biotechnologies, Inc., Lonza Group, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Analytix GmbH by Dilarus GmbH, Nelson Laboratories, LLC by Sotera Health, North American Science Associates, LLC, Pacific BioLabs, Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
  • Assays, Kits, & Reagents
  • Instruments
  • Services

• Test Type
  • Limulus Amoebocyte Lysate
    • Chromogenic Tests
    • Gel Clot Tests
    • Turbidimetric Tests

• Monocyte Activation Test
• Rabbit Tests
• Recombinant Cascade Reagent
• Recombinant Factor C

• End-User
  • Biotechnology Companies
  • Medical Device Companies
  • Pharmaceutical Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pyrogen Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pyrogen Testing Market?

3. What are the technology trends and regulatory frameworks in the Pyrogen Testing Market?

4. What is the market share of the leading vendors in the Pyrogen Testing Market?

5. Which modes and strategic moves are suitable for entering the Pyrogen Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of infectious diseases and chronic diseases
    • 5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical devices products
    • 5.1.1.3. Stringent regulations and standards set by health authorities worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the advanced pyrogen testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in R&D activities by pharmaceutical and biotechnology companies
    • 5.1.3.2. Technological advancements in biotechnology and pyrogen testing technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Operational and ethical concerns associated with the pyrogen testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
  • 5.2.2. End-User: Increasing demand of pyrogen testing across biotechnology companies
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Pyrogen Testing Market, by Product Type

• 6.1. Introduction
• 6.2. Assays, Kits, & Reagents
• 6.3. Instruments
• 6.4. Services

7. Pyrogen Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Limulus Amoebocyte Lysate
• 7.3. Monocyte Activation Test
• 7.4. Rabbit Tests
• 7.5. Recombinant Cascade Reagent
• 7.6. Recombinant Factor C

8. Pyrogen Testing Market, by End-User

• 8.1. Introduction
• 8.2. Biotechnology Companies
• 8.3. Medical Device Companies
• 8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pyrogen Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
  • 12.3.2. Lonza Introduces Advanced Rapid MAT Systems
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio